gininventor

Doug Gin, Stephanie Bryant and Ted Randolph Receive 2007 Awards from Technology Transfer Office

The University of Colorado’s Technology Transfer Office, ranked eighth nationally for the number of companies created and 11th for gross revenue, presented its annual awards January 14 to researchers working in areas ranging from leukemia treatments to lasers in homeland security applications, and to companies supporting innovation. The awards event, held at the historic Tivoli Turnhalle, was attended by more than 200 local business leaders and faculty inventors. Following a talk by Colorado Governor Bill Ritter, awards were presented to inventors, companies and others who demonstrate best practices in technology transfer.

Awards were given to:

Dr. Douglas L. Gin, Inventor of the Year, Boulder. Professor of Chemical and Biological Engineering and of Chemistry and Biochemistry. Research group is applying organic synthesis and molecular design to the construction of functional nanostructured materials.

Dr. Stephanie J. Bryant, New Inventor of the Year, Boulder. Assistant Professor of Chemical and Biological Engineering. Research interests revolve around functional tissue engineering, photopolymerization, and biomaterials.

BaroFold, Inc., Bioscience Company of the Year. BaroFold is a venture backed Boulder-based biopharmaceutical company focused on developing improved biopharmaceuticals for patients suffering from chronic immunologic and auto-immune disorders. The company’s goal is to discover, develop and commercialize protein biologics incorporating its proprietary PreEMT™ high pressure folding technology (a patented technology invented by CU founders Ted Randolph and John Carpenter), along with other state-of-the-art technologies. Since its inception in 2003, the company has leveraged its unique technology to generate licensing agreements with several biopharmaceutical companies, including Genentech, Pfizer, Eli Lilly and, most recently, Avecia Biologics. In May 2007 the company closed a Series A institutional financing round raising $12M.